Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Hepatitis B: new aspects, practical implications. Virology and epidemiology]

F Deinhardt

    Schweizerische Medizinische Wochenschrift
    |April 16, 1977
    PubMed
    Summary

    Hepatitis A and B viruses (HAV, HBV) are identified, enabling diagnosis and leading to recognition of non A--non B hepatitis. A vaccine offers hope for controlling hepatitis B, but challenges remain for routine immunization.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Prevalence of human T-cell lymphotropic virus infections in Germany.

    Journal of medical virology·1994
    Same author

    [A new variant of the simian T-lymphotropic retrovirus type I (STLV-IF) in the Sukhumi colony of hamadryas baboons].

    Voprosy virusologii·1993
    Same author

    Production of human cloned antibodies specific for hepatitis D virus-encoded small and large protein.

    Journal of hepatology·1993
    Same author

    Principal neutralizing domain of HIV-1 is highly immunogenic when expressed on the surface of hepatitis B core particles.

    Vaccine·1993
    Same author

    The immune response to different doses of inactivated hepatitis A vaccine.

    Journal of hepatology·1993
    Same author

    The monoclonal CD4 antibody M-T413 inhibits cellular infection with human immunodeficiency virus after viral attachment to the cell membrane: an approach to postexposure prophylaxis.

    Proceedings of the National Academy of Sciences of the United States of America·1992

    Area of Science:

    • Hepatology
    • Virology
    • Immunology

    Background:

    • Hepatitis A virus (HAV) and Hepatitis B virus (HBV) are significant human pathogens.
    • Neither HAV nor HBV could be cultured in vitro, posing diagnostic challenges.
    • The identification of HAV and HBV paved the way for understanding viral hepatitis.

    Purpose of the Study:

    • To review the advancements in understanding and diagnosing viral hepatitis.
    • To discuss the implications of identifying HAV and HBV.
    • To highlight the development of a vaccine for hepatitis B and its future prospects.

    Main Methods:

    • Literature review of hepatitis research.
    • Analysis of diagnostic advancements for HAV and HBV.
    • Evaluation of epidemiological and pathogenetic data.

    Main Results:

    • HAV and HBV have been identified and characterized.
    • Diagnostic capabilities for hepatitis A and B have been established.
    • A third form, non A--non B hepatitis, has been recognized.
    • HBV has been successfully eliminated from blood products.
    • A vaccine for hepatitis B has been developed, offering potential for control.

    Conclusions:

    • Improved understanding of viral hepatitis epidemiology and pathogenesis.
    • Significant progress in blood safety through HBV elimination.
    • Vaccine development presents a promising strategy for hepatitis B control.
    • Caution and further research are necessary for routine hepatitis B vaccination.

    Related Experiment Videos